Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 77020 · Class II · Belle Bonfils Memorial Blood Center
Key facts
| Event ID | 77020 |
|---|---|
| Recall numbers | B-0586-2017 |
| Recalling firm | Belle Bonfils Memorial Blood Center |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Blood product, in which quality control and distribution of product that did not meet specifications, was distributed. |
| Initiation date | Mar 3, 2017 |
| Report date | May 24, 2017 |
| Termination date | May 15, 2017 |
| City | Denver |
| State | CO |
| Country | United States |
| FEI number | 3000210247 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: